UCB Ventures Belgium
0668.388.891 · rovalta.com · 20/09/2026
UCB Ventures Belgium
Overview
What does UCB Ventures Belgium do?
UCB Ventures Belgium is a Public limited company incorporated in 2016. Its registered office is in Anderlecht.
1070 Anderlecht · BruxellesSee on map
Trend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||
| EBITDA | -15,3 k € | +53.9% | -33,2 k € | +89.7% | -324,0 k € | -331% | -75,2 k € | -44.0% | -52,2 k € | +96.3% | -1,4 M € | -1.1% | -1,4 M € | -78.3% | -787,3 k € | -8576% | -9,1 k € |
| Operating result | -15,3 k € | +53.9% | -33,2 k € | +89.7% | -324,0 k € | -331% | -75,2 k € | -44.0% | -52,2 k € | +96.3% | -1,4 M € | -1.1% | -1,4 M € | -78.3% | -787,3 k € | -8576% | -9,1 k € |
| Net result | 1,9 M € | +67.2% | 1,2 M € | +115% | -7,9 M € | -438% | -1,5 M € | -136% | 4,1 M € | -24.1% | 5,4 M € | +264% | -3,3 M € | -537% | 754,5 k € | +1647% | -48,8 k € |
| Balance sheet | |||||||||||||||||
| Equity | 28,7 M € | +7.3% | 26,8 M € | +4.5% | 25,6 M € | -23.5% | 33,5 M € | -4.2% | 35,0 M € | +13.4% | 30,8 M € | +211% | 9,9 M € | -25.0% | 13,2 M € | +6.1% | 12,5 M € |
| Total assets | 28,8 M € | +5.7% | 27,2 M € | +5.9% | 25,7 M € | -23.4% | 33,5 M € | -4.2% | 35,0 M € | +10.1% | 31,8 M € | +79.4% | 17,7 M € | +23.9% | 14,3 M € | +12.7% | 12,7 M € |
| Cash | 136,7 k € | -94.8% | 2,6 M € | +32322% | 8,2 k € | -96.3% | 219,2 k € | +1262% | 16,1 k € | -99.7% | 4,9 M € | +196190% | 2,5 k € | +289% | 644,0 € | -14.5% | 753,0 € |
| Debts | 27,2 k € | -93.5% | 417,8 k € | +447% | 76,4 k € | +27.2% | 60,1 k € | -9.7% | 66,5 k € | -93.2% | 984,5 k € | -87.4% | 7,8 M € | +608% | 1,1 M € | +336% | 254,0 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 4 active · 16 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Fondation Emmanuel Janssen● Active | 0408.369.901 |
U C B● Active | 0403.053.608 |
UCB Belgium● Active | 0402.040.254 |
UCB BIOPHARMA● Active | 0543.573.053 |
UCB Developed Brands● Active | 1017.533.562 |
UCB Fipar● Active | 0403.198.811 |
UCB PHARMA● Active | 0403.096.168 |
UCB Pillar 2● Active | 1011.675.752 |
UCB Ventures● Active | 0667.816.096 |
UNITE TVA UCB● Active | 0820.436.985 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 20/07/2026 | 03/07/2025 | 16/07/2024 | 21/07/2023 | 15/07/2022 | 30/04/2021 |
| General meeting | 29/06/2026 | 30/06/2025 | 24/06/2024 | 26/06/2023 | 27/06/2022 | 27/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
10 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 29/06/2026 | 20/07/2026 | French | |
| Full model | 31/12/2024 | 30/06/2025 | 03/07/2025 | French | |
| Full model | 31/12/2023 | 24/06/2024 | 16/07/2024 | French | |
| Full model | 31/12/2022 | 26/06/2023 | 21/07/2023 | French | |
| Full model | 31/12/2021 | 27/06/2022 | 15/07/2022 | French | |
| Full model | 31/12/2020 | 27/04/2021 | 30/04/2021 | French | |
| Full modelCorrection | 31/12/2019 | 29/06/2020 | 15/01/2021 | French | |
| Full model | 31/12/2019 | 29/06/2020 | 22/07/2020 | French | |
| Full model | 31/12/2018 | 24/06/2019 | 15/07/2019 | French | |
| Full model | 31/12/2017 | 25/06/2018 | 29/06/2018 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 25 M€ and 50 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 4 active · 16 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Other08/10/2025STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates25/07/2024DEMISSIONS, NOMINATIONS
- Mandates06/09/2023DEMISSIONS, NOMINATIONS
- Mandates15/12/2022DEMISSIONS, NOMINATIONS
- Mandates22/07/2022DEMISSIONS, NOMINATIONS
- Mandates01/06/2021DEMISSIONS, NOMINATIONS
- Mandates06/11/2020DEMISSIONS, NOMINATIONS
- Mandates28/07/2020DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20251,9 M €↑
- 2024Annual accounts 20241,2 M €↑
- 2023Annual accounts 2023-7,9 M €↓
- 2022Annual accounts 2022-1,5 M €↓
- 2021Annual accounts 20214,1 M €↓
- 2020Annual accounts 20205,4 M €↑
- 2019Annual accounts 2019-3,3 M €↓
- 2018Annual accounts 2018754,5 k €↑
- 2017Annual accounts 2017-48,8 k €
- 22/12/2016IncorporationPublic limited company